Anti-inflammatory potency testing of topical corticosteroids and calcineurin inhibitors in human volunteers sensitized to diphenylcyclopropenone-Reference-Cited by-同舟云学术

Anti-inflammatory potency testing of topical corticosteroids and calcineurin inhibitors in human volunteers sensitized to diphenylcyclopropenone

Published:2018-05-22 Issue:8 Volume:84 Page:1719-1728
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Mose Kristian F.¹²^ORCID,Andersen Flemming¹²,Røpke Mads A.³,Skov Lone⁴,Friedmann Peter S.⁵,Andersen Klaus E.¹²⁶^ORCID

Affiliation:

1. Department of Dermatology and Allergy Centre, Odense University Hospital; University of Southern Denmark; 5000 Odense C Denmark

2. Dermatological Investigations Scandinavia; J.B. Winsløwsvej 9 5000 Odense C Denmark

3. Department of Clinical Pharmacology; LEO Pharma A/S; 2750 Ballerup Denmark

4. Department of Dermato-Allergology, Herlev and Gentofte Hospital; University of Copenhagen; 2900 Hellerup Denmark

5. Division of Infection, Inflammation & Immunity, Sir Henry Wellcome Laboratories; Southampton University Hospitals NHS Trust; Southampton SO16 6YD UK

6. Centre for Innovative Medical Technology, Institute of Clinical Research; University of Southern Denmark; 5000 Odense C Denmark

Funder

Kirsten and Volmer Rask Nielsen's Fond

Kongelig Hofbuntmager Aage Bangs Fond

LEO Pharma Research Foundation

The Faculty of Health Sciences, University of Southern Denmark

The Region of Southern Denmark

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13596/fullpdf

Reference33 articles.

1. Method for comparing percutaneous absorption of steroids;McKenzie;Arch Dermatol,1962

2. Assay of topical corticosteroids: efficacy of suppression of experimental rhus dermatitis in humans;Kaidbey;Arch Dermatol,1976

3. Quantifying anti-inflammatory agents' potency by measurement of response to dinitrochlorobenzene challenge;Rees;J Dermatol Sci,1992

4. SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge;Queille-Roussel;Contact Dermatitis,2000

5. Topical tacrolimus 0.1% ointment (Protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema;Alomar;Contact Dermatitis,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Avoidance: Advanced Therapies for Contact Dermatitis;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

2. Systemic allergic contact dermatitis to palladium, platinum, and titanium: mechanisms, clinical manifestations, prevalence, and therapeutic approaches;MedComm;2023-10-21

3. Management von Kontaktekzemen;Allergo Journal;2023-05

4. Management of contact dermatitis;Allergo Journal International;2023-03-20

5. Use of Iontophoresis with Corticosteroid in Carpal Tunnel Syndrome: Systematic Review and Meta-Analysis;International Journal of Environmental Research and Public Health;2023-02-28